Application of Ideal Binary Masking to Disordered Speech
NCT ID: NCT05244603
Last Updated: 2025-03-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
435 participants
INTERVENTIONAL
2021-12-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Hearing Aid Benefit
NCT05198713
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
NCT06053190
Spectral Dynamics and Speech Understanding by Hearing Impaired People
NCT01867515
Speech Intelligibility and Cognition: Are Inpatients Impaired by Noise?
NCT00695162
Tracking Biomarkers of Speech Intelligibility
NCT05145946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Hearing
Listeners with normal hearing
Ideal binary mask
Speech in noise processed by ideal binary mask to reduce background noise
Hearing Impaired
Listeners with hearing loss
Ideal binary mask
Speech in noise processed by ideal binary mask to reduce background noise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ideal binary mask
Speech in noise processed by ideal binary mask to reduce background noise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No history of speech or language impairment
* No significant prior contact with persons having neurogenic speech disorders
* 18 to 70 years of age
* Auditory thresholds of 20 dB HL or better bilaterally at octave frequencies from 250-8000 Hz (if under 55 years of age)
* Auditory thresholds of 25 dB HL or better bilaterally at octave frequencies from 250-4000 Hz (if over 55 years of age)
* 18 to 90 years of age
Exclusion Criteria
* Conductive or mixed hearing loss
* Asymmetric hearing loss
* Obvious concomitant cognitive or mental impairment
* Unable to achieve upward of 20% words correct
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Utah State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Leopold
Primary Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Utah State University
Logan, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Borrie SA, Yoho SE, Healy EW, Barrett TS. The Application of Time-Frequency Masking To Improve Intelligibility of Dysarthric Speech in Background Noise. J Speech Lang Hear Res. 2023 May 9;66(5):1853-1866. doi: 10.1044/2023_JSLHR-22-00558. Epub 2023 Mar 21.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10710
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.